Medical News

RSS

Study links cancer growth to sugar-based modification found naturally in the body

Researchers at Drexel University College of Medicine have discovered that a certain type of sugar found naturally in the body is elevated in breast cancer cells and is critical for cancer growth and movement. When researchers reduced and normalized the levels of this sugar, they were able to slow the growth of the cancer cells and block invasion. The findings, published in the March 1 issue of Oncogene, represent a potential new therapeutic target for treating aggressive forms of breast cancer.

15 Apr 2010

Senate gridlock hurts seniors' health: Medicare physician payment down to the wire

“Medicare physician payment comes down to the wire today as the Senate scrambles once again to delay the 21 percent Medicare cut before physicians feel the impact in their payments this week and a Medicare meltdown begins. Congress’ failure to stave off the Medicare physician payment cut leaves physicians in limbo and puts seniors’ access to care and choice of physician in serious jeopardy. This continued uncertainty coupled with the fact that Medicare payments, even without the 21 percent cut, have not kept up with the cost of providing care to seniors demonstrates the need for a permanent solution to this annual problem.

15 Apr 2010

Pennsylvania Medical Society comments on court ruling against state

The following is a statement from James A. Goodyear, MD, president of the Pennsylvania Medical Society, regarding a Commonwealth Court 4-1 ruling indicating the state should not have diverted money from the Mcare Fund and Health Care Provider Retention Account to help with state budget problems.

15 Apr 2010

Sonic Innovations to unveil new 12-channel BTE hearing aid at AudiologyNOW! conference

Sonic Innovations, Inc. will unveil its new 12-channel super power behind-the-ear (BTE) hearing aid, Endura, at the AudiologyNOW! conference in San Diego, California, April 14 through 17. Endura provides exceptional amplification for those suffering from severe-to-profound hearing loss.

15 Apr 2010

Sorrento Therapeutics completes construction of fully human mAbs library

Sorrento Therapeutics, Inc. today announced that it has completed the construction of an extensive library of full-length, fully human monoclonal antibodies (mAbs). Initial analysis indicates a potential diversity of more than one trillion unique mAbs. The company believes this makes its library the largest full-length, fully human antibody library available for drug discovery and development partnerships.

15 Apr 2010

Lauric-acid-filled nano-scale bombs for treating acne

A natural product found in both coconut oil and human breast milk - lauric acid -- shines as a possible new acne treatment thanks to a bioengineering graduate student from the UC San Diego Jacobs School of Engineering. The student developed a "smart delivery system" - published in the journal ACS Nano in March - capable of delivering lauric-acid-filled nano-scale bombs directly to skin-dwelling bacteria (Propionibacterium acnes) that cause common acne.

15 Apr 2010

Celgene, Agios Pharmaceuticals form global strategic collaboration on targeting cancer metabolism

Celgene Corporation and Agios Pharmaceuticals Inc., a privately-held biotechnology company, today announced the formation of a global strategic collaboration focused on targeting cancer metabolism. The goal of the collaboration is to discover, develop, and deliver novel disease-altering therapies in oncology based on the transformational science of Agios' innovative cancer metabolism research platform. This platform is based on the concept that targeting key metabolic enzymes unique to rapidly proliferating cancer cells can "starve" the cancer.

15 Apr 2010

Repros Therapeutics announces compliance for continued listing on Nasdaq Capital Market

Repros Therapeutics Inc. today announced that it believes that it has regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market.

15 Apr 2010

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class anti-infectives for the treatment and prevention of antibiotic-resistant infections, today reported positive results of an open-label Phase 2a trial of NVC-422 in chronically catheterized patients with significant bacteriuria, or bacteria in the urine. The study showed that NVC-422 was well tolerated and reduced or eliminated certain pathogens in the urine.

15 Apr 2010

Exclusive licensing practices slows innovation in gene testing market

Exclusive licenses to gene patents, most of which are held by academic institutions and based on taxpayer-funded research, do more to block competition in the gene testing market than to spur the development of new technologies for gauging disease risk, say researchers at the Duke Institute for Genome Sciences & Policy (IGSP).

15 Apr 2010

Momenta Pharmaceuticals to present data on M402 drug candidate at 101st AACR meeting

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex mixture drugs, today announced that preclinical data for its novel drug candidate, M402, will be presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR). The meeting will be held April 17-21, 2010 in Washington, DC.

15 Apr 2010

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc will launch extensions to its ACTICOAT(TM) Silver Coated Antimicrobial Barrier Dressing portfolio at the upcoming Symposium on Advanced Wound Care Spring meeting April 17-19, 2010, in Orlando, FL. The new dressings will be highlighted at the Smith & Nephew booth, #301.

15 Apr 2010

Complete Women's Imaging selects Merge Healthcare as IT partner

Merge Healthcare today announced that it was selected by Complete Women's Imaging, P.C., a designated Breast Imaging Center of Excellence by the American College of Radiology (ACR) and the Commission on Breast Imaging, to provide a complete diagnostic imaging workflow and physician reporting solution to the Atlantic Coastal Plain region of New York.

15 Apr 2010

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Despite national guidelines aimed at improving sexual health services for teenagers, most sexually active boys - even those who report high-risk sexual behaviors - still get too little counseling about HIV and other sexually transmitted infections (STIs) during their visits to the doctor, according to a study led by researchers at Johns Hopkins Children's Center.

15 Apr 2010

Texas Health, LHP form joint venture to acquire Wilson N. Jones Medical Center

Texas Health Resources, the largest health care system in North Texas in terms of patients served, and LHP Hospital Group, Inc., have formed a joint venture to acquire Wilson N. Jones Medical Center in Sherman, Texas. Texas Health will own a majority equity interest in the joint venture that owns Texas Health Presbyterian Hospital-WNJ and LHP will manage the operation of the hospital.

15 Apr 2010

Early, accurate detection of superficial bladder cancer with Olympus PDD

With Olympus photodynamic diagnosis (PDD), superficial bladder cancer can be detected earlier, easier and more accurately. Bladder cancer is diagnosed by cystoscopy, the endoscopic introduction of a light source through the urethra (transurethral) into the bladder. The imaging technology PDD uses blue light to increase the contrast between tumour tissue (red) and healthy tissue (blue).

From Evident Corporation - Life Sciences 15 Apr 2010

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Foundation Medicine, a personalized cancer medicine company that aims to bring comprehensive cancer genome analysis into routine clinical care, today announced it has completed a $25 million Series A financing led by Third Rock Ventures.

15 Apr 2010

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has requested Scientific Advice from the European Medicines Agency (EMA) to assure the acceptability of the recently initiated Phase 3 programs for the development of its lead anticancer compound, perifosine, in its two lead indications, multiple myeloma and refractory advanced colorectal cancer.

15 Apr 2010

HHS: Early retiree claim forms for new temporary program to help businesses will be ready in June

Business Insurance: The Department of Health and Human Services says that reimbursement forms to have the federal government help pay employers for early retiree health care claims will be available in June.

15 Apr 2010

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.

15 Apr 2010

Medical News

Study links cancer growth to sugar-based modification found naturally in the body

Senate gridlock hurts seniors' health: Medicare physician payment down to the wire

Pennsylvania Medical Society comments on court ruling against state

Sonic Innovations to unveil new 12-channel BTE hearing aid at AudiologyNOW! conference

Sorrento Therapeutics completes construction of fully human mAbs library

Lauric-acid-filled nano-scale bombs for treating acne

Celgene, Agios Pharmaceuticals form global strategic collaboration on targeting cancer metabolism

Repros Therapeutics announces compliance for continued listing on Nasdaq Capital Market

Positive results from NovaBay Pharmaceuticals' Phase 2a trial of NVC-422

Exclusive licensing practices slows innovation in gene testing market

Momenta Pharmaceuticals to present data on M402 drug candidate at 101st AACR meeting

Smith & Nephew to launch new line extensions to ACTICOAT antimicrobial barrier dressing portfolio

Complete Women's Imaging selects Merge Healthcare as IT partner

Despite national guidelines, teen boys still get inadequate HIV/STI counseling

Texas Health, LHP form joint venture to acquire Wilson N. Jones Medical Center

Early, accurate detection of superficial bladder cancer with Olympus PDD

Foundation Medicine completes $25M Series A financing led by Third Rock Ventures

Æterna Zentaris Zentaris requests EMA Scientific Advice for Phase 3 program with perifosine

HHS: Early retiree claim forms for new temporary program to help businesses will be ready in June

AVANIR Pharmaceuticals presents Phase III trial data of Zenvia for PBA at AAN Annual Meeting

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News